VanEck Associates’s Core Scientific CORZ Stock Holding History

VanEck Associates’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.2M	Buy	1,728,660 +72,729	+4%	+$1.71M	0.03%	305
2026 Q1	$24.8M	Buy	1,655,931 +23,492	+1%	+$401K	0.02%	396
2025 Q4	$23.8M	Buy	1,632,439 +641,454	+65%	+$11.2M	0.02%	364
2025 Q3	$17.8M	Sell	990,985 -1,235,569	-55%	-$18.1M	0.02%	388
2025 Q2	$38M	Sell	2,226,554 -293,819	-12%	-$2.94M	0.04%	244
2025 Q1	$18.2M	Buy	2,520,373 +480,655	+24%	+$5.47M	0.02%	336
2024 Q4	$28.7M	Buy	2,039,718 +422,774	+26%	+$6.25M	0.04%	259
2024 Q3	$21.9M	Buy	1,616,944 +300,942	+23%	+$3.12M	0.03%	285
2024 Q2	$12.2M	Buy	+1,316,002	New	+$6.72M	0.02%	372

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

VanEck Associates's CORZ Position: Q2 2026 in Review

VanEck Associates increased its Core Scientific (CORZ) stake by 4.4% in Q2 2026, buying an estimated $1.71M and bringing the position to 1,728,660 shares worth $44.2M. The position accounts for 0.03% of the portfolio, ranked #305.

VanEck Associates first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

VanEck Associates held 1,728,660 shares of Core Scientific worth $44.2M as of Q2 2026.
VanEck Associates bought 72,729 Core Scientific shares in Q2 2026, an estimated $1.71M.
Core Scientific made up 0.03% of VanEck Associates's portfolio in Q2 2026, its #305 holding.
VanEck Associates first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.